Jump to content

Stocks more likely to make profit in footsie 100


Recommended Posts

So far I have not heard any one for Stocks more likely to rise in value and make profit in 2018.

My own view is that Footsie won't go far this year. If not crash but stay 5% to 10% in the range ,what it is at the moment.

My own recommendation for this year for stocks is

1. Legal & General  

2. Sophos

3  GSK

Number 1 & 3 is also more for the Dividends And No 3 is more for the future danger of Cyber attacks

I would like to hear from others their views .

Peter77

Link to post

Peter,

 

its good to hear some suggestions. For LGEN I note this has a yield of 5.3%, which seems reasonable. I looked at a FTSE 100 table and this yield makes LGEN the 12th highest paying FTSE100 stock, based on this value. Interestingly I hold Imperial Brands, which is the 11th highest payer at 5.4% and I too bought this for the yield alone, so in a sense we have both reached the same decision. With IMB I am expecting capital growth over the next 12 months because a) it is a defensive stock and b) the price has come down from a high of around £41.30 reached in 2017. I expect this correction to be reversed and IMB are investing in new products to protect their market share.

 

I don't however know much about Legal and General!

 

In respect of Sophos, this is not a FTSE100 constituent so not sure if that affects your decision making (it initially looked like you were trying to identify FTSE100 stocks to out perform the index?) I don't know much about it except the stock has roughly doubled over the last 12 months, so it would be a great feat if it were to do that again. (Do you know anything about the company its prospects or its products, btw?) it is on a very punchy rating of f/c PER 121 which is roughly akin to OCADO - a stock that is widely believed to be over-valued. I suppose largely it depends if SOPHOS can meet its profit targets for the year. This only pays 0.6% yield, so I would not be buying it for income, and for me the rating is too punchy to justify buying it now, without doing more research. Perhaps you can write up some notes?

 

In terms of GSK, I do partially resonate your thinking, and in a similar vein to LGEN, this could be a good buy for the yield of 6.1%, but perhaps with a bounce in the share price too. Perhaps there is M&A potential here?

I have held this share before, and given the three you picked then GSK would be my preference as the dividend yield is the highest of the three with some chance of share price growth too.

(note the cover is < 1 so is there a risk the dividend could be cut or frozen?)

 

You may want to plot these shares again the FTSE100 and see how they have tracked it, re-basing for say two years.  There is a good piece of work that could be undertaken here.

 

 

 

 

Link to post

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • General Statistics

    • Total Topics
      15,389
    • Total Posts
      73,866
    • Total Members
      62,267
    • Most Online
      7,522
      10/06/21 10:53

    Newest Member
    AdamChao
    Joined 13/06/21 09:16
  • Posts

    • Fraud, corruption, censorship and the Covidian Cult.   ''The Wuhan/Covid fraud and corruption goes to the very top of the mainstream media establishment. Just in case that wasn't already obvious.''  zerohedge @zerohedge 'The @pulitzercenter is covering up its ties to @PeterDaszak and @EcoHealthNYC! They have removed him from the page of the 2016 conference on future pandemics, where Daszak revealed how his Chinese friends are building killer viruses.'   YouTube censorship ...   The rules are for Thee not for We.   And the 'We' are all in this together.   .
    • 10 years old and still just as relevant.  
    • Oh, so underlying conditions are significant now we have the vaccines, ''98% of ALL COVID-19 deaths in English hospitals were people with underlying conditions. The evening standard is trying to defend the vaccine by saying that the people who died with two doses had underlying health issues. See the problem?'' datatosee.com  @dontbetyet     MEANWHILE, - What? ''WHOA!! 73% *HIGHER* death rate in this vaccinated UK cohort compared to the unvaccinated (19/9344 vs 23/19573, p=0.07). Pause. We need more transparency on this data, not more politics with people ... misrepresenting the data.''  Dr Ah Kahn Syed @arkmedic   Also meanwhile, ''Pandemrix was pulled for causing narcolepsy in 20 in a million doses. The crude reporting rate for myocarditis is 35 per million doses for 16-17 year olds [covid vaccines] ''  Dr Clare Craig @ClareCraigPath  (Chart taken from FDA video below).        .
×
×
  • Create New...